Results 61 to 70 of about 3,487 (207)

Neuroophthalmological evaluation in primary inflammatory demyelinating diseases with special reference to optic neuritis: A prospective study

Journal of Family Medicine and Primary Care
Introduction: The involvement of ocular system especially optic neuritis (ON) is an important clinical aspect of inflammatory demyelinating disease (IDD) of the central nervous system.
Ankit Khetan, Rajesh Verma, Rajarshi Chakraborty, Ravindra Kumar Garg, Hardeep Singh Malhotra, Praveen Kumar Sharma, Neeraj Kumar, Ravi Uniyal, Shweta Pandey, Imran Rizvi   +9 more
doaj   +1 more source

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder

Frontiers in Immunology, 2022
Autoantibody-associated demyelinating diseases of the central nervous system such as myelin oligodendrocyte glycoprotein-antibody associated disease (MOGAD) and aquaporin 4-antibody positive neuromyelitis optica spectrum disorders (AQP4+ NMOSD) are rare ...
Angelika Bauer, Angelika Bauer, Dagmar Rudzki, Dagmar Rudzki, Klaus Berek, Alessandro Dinoto, Christian Lechner, Eva-Maria Wendel, Harald Hegen, Florian Deisenhammer, Thomas Berger, Thomas Berger, Romana Höftberger, Romana Höftberger, Kevin Rostasy, Sara Mariotto, Markus Reindl   +16 more
doaj   +1 more source

Intracranial Pressure Elevation and MOGAD

JAMA Neurology
This cross-sectional study examines the frequency of increased intracranial pressure and its association with myelin oligodendrocyte glycoprotein antibody-associated disease in patients of various ages.
Tisavipat, Nanthaya, Rattanathamsakul, Natthapon, Salman, Abdul-Rahman, Cacciaguerra, Laura, Pittock, Sean J., Flanagan, Eoin P., Chen, John J.   +6 more
openaire   +3 more sources

Image_3_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.TIF

, 2022
BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS.
Omri Zveik (12283328), Ariel Rechtman (12283325), Benjamin Uliel (12283331), Atira S. Bick (12283337), Livnat Brill (3425690), Adi Vaknin-Dembinsky (110061), Netta Levin (711894), Nitzan Haham (12283334)   +7 more
core   +1 more source

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

Frontiers in Neurology, 2023
Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases, including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and cerebral cortical encephalitis.
Osman Corbali, Osman Corbali, Tanuja Chitnis, Tanuja Chitnis   +3 more
doaj   +1 more source

Table_4_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX

, 2022
BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS.
Omri Zveik (12283328), Ariel Rechtman (12283325), Benjamin Uliel (12283331), Atira S. Bick (12283337), Livnat Brill (3425690), Adi Vaknin-Dembinsky (110061), Netta Levin (711894), Nitzan Haham (12283334)   +7 more
core   +1 more source

Laser-Assisted In Situ Keratomileusis Surgery on a Patient with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease or Neuromyelitis Optica Spectrum Disorder

Case Reports in Ophthalmological Medicine, 2023
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorder (NMOSD) are rare central demyelinating diseases that may affect refractive surgery outcomes.
Majid Moshirfar, Duncan J. Williams, Melody Ziari, Meagan D. Seay, Yasmyne C. Ronquillo   +4 more
doaj   +1 more source

Table_1_Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.DOCX

, 2022
BackgroundMyelin oligodendrocyte glycoprotein antibody disorders (MOGAD) have evolved as a distinct group of inflammatory, demyelinating diseases of the CNS.
Omri Zveik (12283328), Ariel Rechtman (12283325), Benjamin Uliel (12283331), Atira S. Bick (12283337), Livnat Brill (3425690), Adi Vaknin-Dembinsky (110061), Netta Levin (711894), Nitzan Haham (12283334)   +7 more
core   +1 more source

MOGAD: A novel disease

Indian Journal of Clinical and Experimental Ophthalmology
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an immune-mediated inflammatory neurological disease and a new addition to the demyelinating disorders of the central nervous system(CNS).In MOGAD, specific antibodies (MOG IgG) targeting MOG protein lead to primary demyelination in the CNS, but notably spare astrocytes.
Ziaul Haq Yasir, Tushar Kant Singh, Rakesh Sharma, Mukesh Kumar   +3 more
openaire   +1 more source

MOGAD: MOG-antistof-gerelateerde ziekte

Tijdschrift voor Neurologie en Neurochirurgie, 2022
MOG-antistof-gerelateerde ziekte is een zeldzame neuro-inflammatoire ziekte van het centraal zenuwstelsel die voorkomt bij zowel kinderen als volwassenen. Het klinisch fenotype is sterk leeftijdsafhankelijk. Acute gedissemineerde encefalomyelitis komt vooral voor bij jonge kinderen, en recidiverende neuromyelitis optica bij oudere kinderen en ...
Willekens, Barbara, Bruijstens, Arlette, Neuteboom, Rinze, Smolders, Joost, Wokke, Beatrijs   +4 more
openaire   +2 more sources